Centro Hospitalar de Entre o Douro e Vouga, E.P.E. - Hospital de São Sebastião
Santa Maria da Feira 4520-211
0 studies enrolling now · 7 studies all time
What they study most
Alzheimer Disease, Breast Cancer, Carcinoma, Non-Small-Cell Lung, Diabetes Mellitus, Type 2, First Line Non-Small Cell Lung Cancer, Secondary Prevention, Stroke, Ulcerative Colitis
Studies at this site
- ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1 — Completed
- Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04] — Running, not enrolling
- Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
- Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer — Completed
- CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes — Completed
- Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) — Completed
- BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease. — Completed